4.6 Article

Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi

Christelle Charbel et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Article Neurosciences

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor

Heidi V. N. Kusters-Vandevelde et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)

Article Multidisciplinary Sciences

Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma

Xinqi Wu et al.

PLOS ONE (2013)

Article Oncology

Heat shock proteins as targets in oncology

Alejandra Gimenez Ortiz et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2010)

Article Dermatology

The Risk of Melanoma and Neurocutaneous Melanosis Associated with Congenital Melanocytic Nevi

Kara N. Shah

SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2010)

Article Surgery

Giant Congenital Melanocytic Nevi

Jugpal S. Arneja et al.

PLASTIC AND RECONSTRUCTIVE SURGERY (2009)

Review Biochemistry & Molecular Biology

Thrombospondins in cancer

S. Kazerounian et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2008)